BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 24295296)

  • 1. N-succinyl chitosan as buccal penetration enhancer for delivery of herbal agents in treatment of oral mucositis.
    Dhawan N; Kumar K; Kalia AN; Arora S
    Curr Drug Deliv; 2014; 11(3):415-25. PubMed ID: 24295296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chitosan delivery systems for the treatment of oral mucositis: in vitro and in vivo studies.
    Aksungur P; Sungur A; Unal S; Iskit AB; Squier CA; Senel S
    J Control Release; 2004 Aug; 98(2):269-79. PubMed ID: 15262418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro characterization of chitosan gels for buccal delivery of celecoxib: influence of a penetration enhancer.
    Cid YP; Pedrazzi V; de Sousa VP; Pierre MB
    AAPS PharmSciTech; 2012 Mar; 13(1):101-11. PubMed ID: 22160883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thermally sensitive gels based on chitosan derivatives for the treatment of oral mucositis.
    Rossi S; Marciello M; Bonferoni MC; Ferrari F; Sandri G; Dacarro C; Grisoli P; Caramella C
    Eur J Pharm Biopharm; 2010 Feb; 74(2):248-54. PubMed ID: 19854272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chitosan-based mucoadhesive gel for oral mucosal toluidine blue O delivery: The influence of a non-ionic surfactant.
    Garcia MTJ; de Paula Freitas C; Graciano TB; Coutinho TS; Cressoni CB; de Lima Pereira SA; Shimano MM
    Photodiagnosis Photodyn Ther; 2017 Dec; 20():48-54. PubMed ID: 28838759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, characterization and ex vivo evaluation of chitosan film integrating of insulin nanoparticles composed of thiolated chitosan derivative for buccal delivery of insulin.
    Mortazavian E; Dorkoosh FA; Rafiee-Tehrani M
    Drug Dev Ind Pharm; 2014 May; 40(5):691-8. PubMed ID: 24524272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mucoadhesive thermosensitive hydrogel containing erythropoietin as a potential treatment in oral mucositis: in vitro and in vivo studies.
    Rezazadeh M; Jafari N; Akbari V; Amirian M; Tabbakhian M; Minaiyan M; Rostami M
    Drug Deliv Transl Res; 2018 Oct; 8(5):1226-1237. PubMed ID: 30076521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chitosan and gelatin based prototype delivery systems for the treatment of oral mucositis: from material to performance in vitro.
    Perchyonok VT; Zhang S; Oberholzer T
    Curr Drug Deliv; 2013 Feb; 10(1):144-50. PubMed ID: 23017090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of improved buccal permeation and bioavailability of felodipine microemulsion-based cross-linked polycarbophil gel.
    Singh M; Kanoujia J; Parashar P; Arya M; Tripathi CB; Sinha VR; Saraf SK; Saraf SA
    Drug Deliv Transl Res; 2018 Jun; 8(3):591-601. PubMed ID: 29423833
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polyvinylpyrrolidone-sodium hyaluronate gel (Gelclair): a bioadherent oral gel for the treatment of oral mucositis and other painful oral lesions.
    Buchsel PC
    Expert Opin Drug Metab Toxicol; 2008 Nov; 4(11):1449-54. PubMed ID: 18950285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of lauryl succinyl chitosan particles towards oral insulin delivery and absorption.
    Rekha MR; Sharma CP
    J Control Release; 2009 Apr; 135(2):144-51. PubMed ID: 19331862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lyophilized sustained release mucoadhesive chitosan sponges for buccal buspirone hydrochloride delivery: formulation and in vitro evaluation.
    Kassem MA; ElMeshad AN; Fares AR
    AAPS PharmSciTech; 2015 Jun; 16(3):537-47. PubMed ID: 25370025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Buccal delivery of acyclovir from films based on chitosan and polyacrylic acid.
    Rossi S; Sandri G; Ferrari F; Bonferoni MC; Caramella C
    Pharm Dev Technol; 2003; 8(2):199-208. PubMed ID: 12760570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-assembled liposome from core-sheath chitosan-based fibres for buccal delivery of carvedilol: formulation, characterization and in vitro and ex vivo buccal absorption.
    Chen J; Pan H; Duan H; Deng W; Zhang F; Yang X; Pan W
    J Pharm Pharmacol; 2020 Mar; 72(3):343-355. PubMed ID: 31863466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiolated chitosan: development and in vivo evaluation of an oral delivery system for leuprolide.
    Iqbal J; Shahnaz G; Perera G; Hintzen F; Sarti F; Bernkop-Schnürch A
    Eur J Pharm Biopharm; 2012 Jan; 80(1):95-102. PubMed ID: 21964316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using chitosan gels as a toluidine blue O delivery system for photodynamic therapy of buccal cancer: In vitro and in vivo studies.
    Graciano TB; Coutinho TS; Cressoni CB; Freitas Cde P; Pierre MB; Pereira SA; Shimano MM; Frange RC; Garcia MT
    Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):98-107. PubMed ID: 25463317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucoadhesive Buccal Tablets Based on Chitosan/Gelatin Microparticles for Delivery of Propranolol Hydrochloride.
    Abruzzo A; Cerchiara T; Bigucci F; Gallucci MC; Luppi B
    J Pharm Sci; 2015 Dec; 104(12):4365-4372. PubMed ID: 26505621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional characterisation and permeation studies of lyophilised thiolated chitosan xerogels for buccal delivery of insulin.
    Boateng JS; Mitchell JC; Pawar H; Ayensu I
    Protein Pept Lett; 2014; 21(11):1163-75. PubMed ID: 25101633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic efficacy of rebamipide-loaded PLGA nanoparticles coated with chitosan in a mouse model for oral mucositis induced by cancer chemotherapy.
    Takeuchi I; Kamiki Y; Makino K
    Colloids Surf B Biointerfaces; 2018 Jul; 167():468-473. PubMed ID: 29723818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Delivering Resveratrol on the Buccal Mucosa Using Mucoadhesive Tablets: A Potential Treatment Strategy for Inflammatory Oral Lesions.
    Martins ICF; Raposo NRB; Mockdeci HR; Polonini HC; de Oliveira Ferreira A; Fabri GMC; das Gracas Afonso Miranda Chaves M
    Curr Drug Deliv; 2018 Feb; 15(2):254-259. PubMed ID: 28745229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.